首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1593528

人工骨替代材料市場規模、佔有率和成長分析（按材料類型、應用、最終用戶和地區）：產業預測（2024-2031）

Bone Graft Substitutes Market Size, Share, Growth Analysis, By Material Type (Allograft, Synthetic), By Application (Craniomaxillofacial, Joint Reconstruction), By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月10日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球骨移植及其替代品市場規模估值為12億美元，從2023年的12.8億美元成長到2031年的21.5億美元，預計在預測期內成長（2024年預計複合年成長率為2031年至2031 年期間將成長6.70%。

由於合成替代品的日益普及以及監管機構核准的創新產品的推出，全球人工骨替代材料市場預計將出現強勁成長。特別是，百特於 2020 年 7 月獲得 FDA 批准的 Altapore Shape 生物活性骨移植物反映了這一趨勢。骨移植物及其替代品的使用由於其生物相容性、安全性和促進骨癒合而越來越受到青睞，這凸顯了對最大限度地減少副作用的生物相容性解決方案的需求正在迅速增加。合成植入物，尤其是那些注射到羥磷石灰(HAp) 和磷酸三鈣 (TCP) 的植入物，由於其高相容性而成為流行的替代品。例如，Graftys 認證的骨空隙填充劑以及 Molecular Matrix 推出先進的 Osteo-P 合成骨移植替代品。其他好處包括更快的恢復時間、更短的住院時間和更小的切口。美國整形外科學會（AAOS）的資料顯示，關節鏡手術、脊椎手術、骨折修復、全關節重建等微創整形外科手術在美國穩定成長，而這些手術都人工骨替代材料。市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 波灣合作理事會(GCC) 國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

AlloSource（美國）
史密斯+侄子（英國）
Medtronic (Ireland)
Orthofix US LLC（美國）
Pietro Fiorentini SpA（義大利）
TBF（法國）
OST 實驗室（法國）
蓋氏製藥股份公司（瑞士）
史賽克（美國）
生物銀行（英國）
愛知時計電機株式會社（日本）
重慶山城燃氣設備有限公司 (中國)
Flonidan A/S（丹麥）
EMH 計量有限公司 (德國)
Badger Meter, Inc.（美國）
威勝集團控股有限公司（星寶投資控股有限公司）（中國）
華立科技有限公司（華立集團）（中國）
前衛克羅姆施羅德儀表有限公司 (中國)
安全儀表有限公司（印度）
IMAC 系統公司（美國）
Metrix 儀表（波蘭）

簡介目錄

Product Code: SQMIG35A2257

Global Bone Grafts and Substitutes Market size was valued at USD 1.2 billion in 2022 and is poised to grow from USD 1.28 billion in 2023 to USD 2.15 billion by 2031, growing at a CAGR of 6.70% during the forecast period (2024-2031).

The global market for bone graft substitutes is poised for robust growth driven by the rising preference for synthetic substitutes and the introduction of innovative products approved by regulatory bodies. Notably, Baxter's FDA clearance in July 2020 for its Altapore Shape Bioactive Bone Graft exemplifies this trend. The incorporation of bone grafts and substitutes is increasingly favored due to their biocompatibility, safety profile, and promotion of bone healing, with a notable surge in demand for biocompatible solutions that minimize adverse reactions. Synthetic grafts, particularly those infused with Hydroxyapatite (HAp) and Tricalcium Phosphate (TCP), have emerged as popular alternatives due to their enhanced compatibility. Regulatory support and proactive product development strategies by market players are further bolstering market expansion, highlighted by Graftys' certification of its bone void fillers and Molecular Matrix's launch of the advanced Osteo-P Synthetic Bone Graft Substitute. Additionally, the trend toward minimally invasive procedures enhances the demand for bone grafts due to benefits such as reduced recovery time, shorter hospital stays, and smaller incisions. Data from the American Academy of Orthopedic Surgeons (AAOS) indicates a steady rise in minimally invasive orthopedic procedures in the United States, including arthroscopy, spine surgeries, fracture repairs, and joint replacements, all of which significantly contribute to the accelerated growth of the bone graft substitute market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone Grafts And Substitutes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Grafts And Substitutes Market Segmental Analysis

Global Bone Grafts and Substitutes Market is segmented by Material Type, Application, End User and Region. Based on Material Type, the market is segmented into Allograft, Synthetic. Based on Application, the market is segmented into Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, and Spinal Fusion. Based on End User, the market is segmented into Hospitals, Specialty clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Bone Grafts And Substitutes Market

A key market driver for the global bone grafts and substitutes market is the rising prevalence of orthopedic conditions and musculoskeletal disorders, fueled by factors such as sedentary lifestyles, an aging population, and a surge in sports-related injuries and accidents. The increasing incidence of fractures and bone-related ailments has escalated the demand for effective bone graft substitutes that facilitate bone regeneration and healing processes. This growing need emphasizes the urgency for innovative and efficient solutions within the market, aimed at addressing the burgeoning patient population and the complexities associated with a variety of orthopedic conditions, thereby driving market growth and development.

Restraints in the Global Bone Grafts And Substitutes Market

A significant market restraint for the global bone grafts and substitutes market is the high cost associated with these advanced medical products. The utilization of sophisticated technologies and premium materials in developing bone graft substitutes drives their prices up, which can limit their adoption, particularly in emerging economies where healthcare budgets are constrained. Furthermore, inadequate reimbursement coverage for these products within various healthcare systems exacerbates the issue, resulting in reduced accessibility for potential patients. This financial barrier presents a considerable challenge for individuals, healthcare practitioners, and systems striving for cost-effective solutions in managing bone-related ailments, thereby impacting overall market growth.

Market Trends of the Global Bone Grafts And Substitutes Market

The global bone grafts and substitutes market is witnessing a significant trend towards the development of bioactive and tissue-engineered grafts, driven by the need for enhanced biocompatibility and accelerated bone healing. Innovations in technologies like 3D printing and nanotechnology are facilitating the production of tailored graft substitutes that boast superior structural and mechanical properties. This trend underscores the industry's focus on pioneering solutions that closely resemble natural bone tissue, yielding better patient outcomes and minimizing complications associated with traditional bone grafting techniques. As a result, the market is evolving towards more advanced and effective graft options, reflecting a commitment to improving surgical results and patient recovery.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Bone Graft Substitutes Market by Material Type

Market Overview
Allograft
- Demineralized Bone Matrix
- Others
Synthetic
- Ceramics
- HAP
- B-TCP
- a-TCP
- Bi-phasic Calcium Phosphates (BCP)
- Others
- Composites
- Polymers
- Bone Morphogenic Proteins (BMP)

Bone Graft Substitutes Market by Application

Market Overview
Craniomaxillofacial
Dental
Foot & Ankle
Joint Reconstruction
Long Bone
Spinal Fusion

Bone Graft Substitutes Market by End User

Market Overview
Hospitals
Specialty clinics
Others

Bone Graft Substitutes Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

AlloSource (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith + Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix US LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pietro Fiorentini S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TBF (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OST Laboratories (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geistlich Pharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biobank (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aichi Tokei Denki Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chongqing Shancheng Gas Equipment Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flonidan A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMH metering GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Badger Meter, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wasion Group Holdings Limited (Star Treasure Investments Holdings Limited) (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Holley Technology Ltd. (Holley Group) (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qianwei Kromschroder Meters Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Secure Meters Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IMAC Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metrix Meter (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments